https://www.selleckchem.com/products/imd-0354.html
The myasthenic syndrome was treated successfully with intravenous immunoglobulins and oral pyridostigmine. Conclusion This is the first case presentation of postinfectious myasthenia gravis as neurological complication in a COVID-19 patient.Purpose Stroke-associated pneumonia (SAP), a common complication in acute ischemic stroke (AIS) patients, is associated with poor prognosis after AIS. Inflammation plays an important role in the development of SAP. In this study, we aimed to explore the association between the monocyte-to-lymphocyte
Like
Comment
Share
